Mini Quiz: Deep Brain Stimulation for Depression

Poll

How effective is deep brain stimulation for treatment-resistant depression? Take the quiz.

Scroll below the feature image for the quiz.

Which of the following is true regarding deep brain stimulation (DBS) for treatment-resistant depression?

A. Response rates are higher than those for electroconvulsive therapy (ECT)
B. Response is sustained, with over 50% of patients continuing to respond at 8 years post-treatment
C. It is an FDA-approved treatment for patients who have not responded to at least 3 serotonergic medications
D. The chance of significant psychological side effects is minimal
Related Videos
Experts on MDD.
Experts on MDD.
Related Content

The Week in Review: September 25-29

September 30th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

Non-Psychiatric Medications With Potential to Worsen Symptoms in Major Depression

September 25th 2023

The Week in Review: September 25-29

September 30th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

Non-Psychiatric Medications With Potential to Worsen Symptoms in Major Depression

September 25th 2023

The Week in Review: September 25-29

September 30th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

Non-Psychiatric Medications With Potential to Worsen Symptoms in Major Depression

September 25th 2023
© 2023 MJH Life Sciences

All rights reserved.